Jeffrey Chou
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 46
- CAR-T cell therapy research 33
- Cancer Immunotherapy and Biomarkers 25
- Immunology 31
- Immunotherapy and Immune Responses 21
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 4
- Co-authors
- Igor Puzanov (8 shared papers)Omid Hamid (14 shared papers)Alan Wells (3 shared papers)Mohammed Milhem (4 shared papers)Howard L. Kaufman (4 shared papers)Kevin Gorski (3 shared papers)David R. Minor (3 shared papers)Lisa Chen (5 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Annals of Oncology (6 papers)Journal for ImmunoTherapy of Cancer (5 papers)Blood (4 papers)Cancer Research (2 papers)
- Partner nations
- United StatesNetherlandsJapan
In The Last Decade
Jeffrey Chou
56 papers receiving 1.7k citations
Jeffrey Chou's Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 1.1k
- Immunology 720
- Hematology 169
- Genetics 410
- Cell Biology 180
Countries citing papers authored by Jeffrey Chou
This map shows the geographic impact of Jeffrey Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Chou more than expected).
Fields of papers citing papers by Jeffrey Chou
This network shows the impact of papers produced by Jeffrey Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Chou. The network helps show where Jeffrey Chou may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey Chou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma Hit paper breakdown → | 2016 | 435 |
| 2 | 2002 | 153 | |
| 3 | 2019 | 126 | |
| 4 | 2016 | 97 | |
| 5 | 2016 | 81 | |
| 6 | 2014 | 69 | |
| 7 | 2019 | 54 | |
| 8 | 2002 | 47 | |
| 9 | 2012 | 45 | |
| 10 | 2019 | 45 | |
| 11 | 2008 | 43 | |
| 12 | 2003 | 41 | |
| 13 | 2017 | 41 | |
| 14 | 2012 | 39 | |
| 15 | 2022 | 37 | |
| 16 | 2019 | 34 | |
| 17 | 2015 | 31 | |
| 18 | 2013 | 30 | |
| 19 | 2014 | 30 | |
| 20 | 2020 | 29 |
About Jeffrey Chou
Jeffrey Chou is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 60 papers that have together received 1.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (33 papers), Cancer Immunotherapy and Biomarkers (25 papers), Immunotherapy and Immune Responses (21 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Immune Cell Function and Interaction (8 papers), Virus-based gene therapy research (6 papers), Cancer Research and Treatments (4 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Oncology (1.1k citations), Immunology (720 citations), Hematology (169 citations), Genetics (410 citations) and Cell Biology (180 citations). Jeffrey Chou has collaborated with scholars based in United States, Netherlands and Japan. Frequent co-authors include Igor Puzanov, Omid Hamid, Alan Wells, Mohammed Milhem, Howard L. Kaufman, Kevin Gorski, David R. Minor, Lisa Chen, Michael Chastain and Abraham Anderson. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal for ImmunoTherapy of Cancer, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.